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High titer erythrocyte cold agglutinins occur most frequently in association 
with  atypical pneumonia  (1,  2),  leukemia,  lymphoma,  and  in  patients  with 
hemolytic  anemia  without  obvious  underlying  disease,  the  so-called  "cold- 
hemagglutinin syndrome" (3; 4, p. 342).  These antibodies have been thought 
to be non-specific in nature in that they usually react with all human eryth- 
rocytes  tested,  although  it  has  been  recognized  that  red  cells  from normal 
individuals  vary widely in  their  sensitivity to agglutination  by a  given anti- 
body  (5).  In  addition,  there  are  several  reports  of  cold  agglutinins  reacting 
preferentially with  group O  cells  (2,  6,  7;  8,  p.  333),  and  one report of their 
acting like a  "pseudo anti-Ax"  (9). 
Knowledge of the anti-I specificity  of some cold agglutinins started with the ob- 
servation of Wiener et al. (10) that the red cells of five individuals,  of over 22,000 tested, 
were not agglutinated at 24°C by a high fiter cold agglutinin. These cells were ag- 
glutinated at 4°C, but to much lower serum dilutions than were other test cells, and 
the agglutinability of both usual and exceptional cells was increased  proportionally 
by treatment with fiein. The antibody was termed anti-I, usual cells were considered 
to be I-positive, and the cells of the five exceptional individuals were designated as 
i, or I-negative. The sara of three of the five i  individuals  were tested for anti-I ag- 
glutinins,  and they possessed low titer cold agglutinins of "average normal fiter." 
In 1960, six additional healthy individuals with type i cells were reported (11, 9), 
three of whom were siblings.  Their cells were agglutinated weakly, or not at all,  at 
20°C by two high titer cold agglutinins,  one of which was the antibody employed pre- 
viously by Wiener (10). The individual whose cells were weakest in I antigen possessed 
a powerful anti-I cold agglutinin; the other five sara also contained anfi-I agglutinins, 
but it is not clear whether their fiters exceeded the normal cold agglutinin range. The 
extremely weak reaction of umbilical cord erythrocytes with anti-I was also noted (11). 
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Marsh  (12) later reported two sera with cold agglutinins which reacted strongly 
with adult i cells and weakly with normal I cells and designated this antibody as anti-i. 
Erythrocytes from newborn infants reacted strongly with the anti-i agglufinins; this 
reactivity gradually declined in strength during the first  18 months of life,  during 
which time I reactivity appeared. 
The limited genetic data  currently available indicate a  recessive  pattern of  in- 
heritance for the adult i phenotype (9; 8, pp. 330-332). 
Although all of  the cold agglutinins studied in the early observations on the  Ii 
system appeared to be specific for either the I or i determinants, Dacie has reported 
five sera and van Loghem et al. fourteen of thirty-nine sera which do not discriminate 
between I and i cells (4, pp. 497, 532; 7). 
During the course  of purification from Ctostridium  tertium  culture filtrates 
of an enzyme which acts on blood group A substance (13-16), it was found that 
a  fraction containing partially purified beta galactosidase  and beta glucosa- 
minidase activities reduced the I activity of human erythrocytes. Both enzymes 
seemed to be needed to  effect maximum reduction in activity. Treatment of 
red cell stroma with these enzymes resulted in a  loss of ability of the stroma 
to absorb anti-I with the liberation of galactose and N-acetylglucosamine as 
monosaccharides,  suggesting  that  these  two  sugars  are  involved  in  the  I 
antigenic determinant. 
Materials and Methods 
Cultivation of Baaerla.--The strain of Clostridium tertium isolated originally by Iseld (13) 
was obtained from Dr.  Calderon Howe. The organisms were cultivated  in the medium de- 
scribed by Howe et a/. (14) with the following  modifications: for induction of both beta gaiac- 
tosidase and beta glucosaminidase activities, a final concentration of 0.05 per cent lactose 
and 0.1 per cent D-glucosamine-HCl was used; to obtain beta galactosidase with much less 
glucosaminidase activity, a final concentration of 0.075 per cent lactose was employed with- 
out added glucosamine. For initiation  of growth and serial passage 10 ml cultures were grown 
in an anaerobic jar at 37°C and transferred  at 48 hour intervals.  For bulk production  of 
enzymes, 6 liter lots of culture medium were inoculated with 100 ml of a 24 hour anaerobic 
culture and incubated aerobically for 48 hours. The bacteria were sedimented by centrifuga- 
tion at 2000 m~M for 1 hour in an International  refrigerated centrifuge model PR-2. 
Fraa{onal~on of Enzymes.--Six  liters of centrifuged culture supernatant were concentrated 
to about 200 ml by dialysis against carbowax  1 20000 and then dialyzed against the chroma- 
tography  starting buffer, 0.01 x,  tris,  ttis(hydroxymethyl)aminomethane,  pH  7.3, 0.9  per 
cent NaC1, and 0.001 ~t Mn  ++. The dialyzed supematant was applied to a 20 gm DEAE 
cellulose  2 column, 3.4 X 20 cm, and the column washed with starting buffer until absorption 
at 2800 A of the effluent was negligible. An NaCl gradient was then imposed, using an ex- 
ternal reservoir containing the limit buffer, 0.01 M tris, pH 7.5, 1.0 ~t NaC1, and 0.001 ~t 
Mn  ++, and two mixing chambers in series, each containing 400 ml of starting buffer. In 
general, the flow rate was 200 ml/hour, and 20 ml fractions were collected. When the column 
effluent no longer exhibited either absorption at 2800 A or enzyme activity,  the column was 
1 Obtained from Union Carbide Chemicals Company, New York. 
2 DEAE selectacel standard,  Schleicher and Schiill Company, Keene, New Hampshire. D. M. MARCUS,  E. A. KABAT~ AND R. E. ROSENFIELD  177 
flushed with the limit buffer. The shape of the gradient was determined by mcasuring the 
conductivity of the fractions with a  serfass conductivity bridge, model RCM 15 Bx 8 
Manganese was used in the chromatography buffer to stabilize the enzyme which acts 
on the blood group A substance. It serves no useful function in the preparation of either beta 
galactosidase or beta glucosaminidase and interferes with the reducing sugar, hexosamine, 
and acetylhexo~mlne assays. 
Enzyme Assays.--Beta galactosidase activity was determined by measuring the hydrolysis 
of o-nitrophenyl beta-D-galactopyranoside  4 (17). The reaction mixture consisted of enzyme, 
buffer, and saline in a  total volume of 0.5 ml, plus 1.0 mg of substrate in a volume of 0.5 ml. 
After 30 minutes at 37°C, 0.5 ml of 0.5 x~ Na~COa  was added and the optical density was 
read at 4050 A. With this substrate, the pH activity curve showed a broad optimum between 
pH 6.0-7.5; assays were performed in a 0.05 M phosphate buffer, pH 7.5, in the early studies, 
and in a 0.02 ~  phosphate buffer, pH 6.5, in the later work. 
Beta glucosaminldase activity was measured by following the hydrolysis of beta methyl-N- 
acetylglucosaminlde.  6 The  reaction  mixture  contained  enzyme,  0.01  xr  phosphate  buffer, 
pH 6.5, and 10.0 #g of substrate in a  total volume of 0.25 ml. After incubation for 1 hour 
at 37°C an analysis for free N-acetylhexosamine was performed as described below. 
A  semiquantitative estimation of peptidase activity was obtained by following the hy- 
drolysis of L-leucylglycylglycine,  6 using the n~nhydrin reaction (18, 16) to measure the increase 
in free amino nitrogen. The reaction mixture contained enzyme, 0.017 M tris buffer, pH 7.5, 
0.004 ~  Mn  "~-, and 15.7 #g of substrate in a  volume of 0.3 mi. After 1 hour at 37°C, 0.1 ml 
of 4.0 M acetate buffer, pH 5.5,  was added, the solutions were mixed, and 0.1 mi of 5.0 per 
cent ninhydrin in methyl celiosolve added. The ninhydrin was activated just before use by 
the addition of 0.05 ml of 0.01 ~  KCN per 2.0 ml of 5 per cent nlnhydrin. The tubes were 
heated in a  water bath at 95°C for 20 minutes, cooled, and 4.5 ml of 50 per cent ethanol 
added;  readings were made at  5700 A. 
Zone Electropkoresis.--Electrophoresls  was performed using pevikon C-870  T as a supporting 
medium (19)  in a  block of dimensions 7.0  X  1.2  X  29.0 cm using the E-C electrophoresls 
apparatus. The buffer employed was 0.07 M phosphate, pH 6.5. Electrophoresis was carried 
out for 17 hours at 200 v, 16 to 24 ma at room temperature, with the block enclosed in a 
jacket through which cold water was circulated. The block was cut into 1.0 cm segments 
which were placed on sintered glass filters of medium porosity, and the enzymes eluted with 
two 2 mi portions of saline, using gentle positive pressure. Protein concentration in the eluates 
was estimated by reading the absorption at 2800 A. 
Hemagglutination.--Blood was preserved at 4°C  in Alsever's solution  (20). Hemaggluti- 
nation and hemagglutination inhibition tests were performed as previously described  (20, 
chapter 3), using light centrifugation. Most of the assays were carried out on a  microscale 
in a total volume of three to four drops, including one drop of 2 per cent or 4 per cent eryth- 
rocytes. When group A cells were used, the anti-A isoagglutinin was neutralized by addition 
of blood group A substance from hog gastric mucin to the anti-I serum. 
Sera.--Sera  were  obtained  from  patients with  hemolytic  anemia  associated  with  cold 
agglutinins. Patient Bu. had a  reticulum cell lymphosarcoma; patient Ch.  a had a  lympho- 
8 Obtained from Arthur H. Thomas Company,  Philadelphia. 
4, Obtained from the California Corporation for Biochemical Research, Los Angeles. 
s Alpha and  beta methyl-N-acetylglucosaminlde were generously supplied  by Professor 
Richard Kuhn. 
6 Obtained from Mann Research Labs,  Inc., New  York. 
7 Obtained from Stockholms Superfosfat Fabriks A.-B.,  Stockholm,  Sweden. 
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sarcoma; patient N.P? had no obvious associated disease. The anti-I specificity of serum 
Bu. was confirmed by Dr. 1~. Race; the anti-I specificity of serum N. P. was documented 
in  reference 21, page 391;  the anti-I specificity of serum Ch. was established by tests with 
various red cells including adults of blood types Bi, Ali, Oi, and numerous samples of cord 
blood cells. Type XIV antipneumococcal horse serum, tI 615, bleeding of 4/15/39, was ob- 
tained from the New York State Department of Health through the courtesy of Dr. Jesse L. 
Hendry. Hemagglutination tests with serum Bu.  were carried out  at  20°C;  all  other sera 
were tested at 4°C. 
Preparation and Treatment of Stroma.--The erythrocytes from an outdated unit of whole 
blood were washed with saline and  the bury coat removed by aspiration. The cells  were 
lysed in 2 liters of saline containing 0.5 gm of digltonin  I° and the stroma washed with saline 
until  the  supernatant  contained  traces  of  hemoglobin. Stroma  preparations  varied  con- 
siderably in their content of residual hemoglobin and in the ease with which they could be 
sedimented; the basis of this variability is not known. The washed stroma preparation was 
divided into two portions, one of which was suspended in a DEAE column fraction containing 
beta galactosidase and beta glucosaminldase, in 0.02  ~x phosphate, 0.15  ~  saline,  pit 6.5, 
and the other portion was suspended in buffer. The total volume of the suspensions varied 
from 45 to 70 ml. The stroma suspensions were placed on a mechanical rotating device and 
incubated at 37°C for 17 to 19 hours, packed by centrifugation in the cold for 1 hour at 2000 
m~x~, washed three times with water, and the pooled superuatants from each preparation 
desalted by passage through amberlite  n  MB 3,  125 gm in a column 4.5  X  14 cm, and con- 
centrated by evaporation under reduced pressure. 
For further purification and characterization of the sugars present in the stroma super- 
natants, chromatography was performed on columns composed of equal weights of darco 
G-60  charcoal and celite No. 535  (22, 16). The blood group A and O stroma superuatants 
were chromatographed on 8 gm columns (4 gm charcoal -b 4 gm celite), 2 X  9 cm, at a flow 
rate of 40 ml/hour; the B  stroma supernatants were chromatographed on a  3 gm column, 
1.2  X  8.5 cm, at a flow rate of 20 ml/hour. 
The effect of enzyme treatment on the I determinant of erythrocyte stroma was evaluated 
by comparing the ability of control and enzyme-treated stroma to absorb cold agglutinins. 
Approximately equal volumes of packed control and enzyme-treated stroma were suspended 
in a 1:5 dilutionof serum Ch., held at 4°C for 1 hour, and centrifuged at 2000 m,~ for 1 hour, 
at 4°C. The supematant sera were aspirated and aliquot portions were subjected to a second 
absorption. 
If the stroma retained appreciable I  activity following the initial overnight enzyme treat- 
ment, an aliquot portion was retreated for 72  hours at twice the initial enzyme:substrate 
ratio. 
Analytical Methods.--Redueing  sugars were measured by a  modification of the procedure 
of Park and Johnson (23,  16). Methylpentose was measured by the method of Dische and 
Shettles (24), and galactose by the method of Dische (25), both on a one-fifth scale. Hexos- 
amine was determined by a  modification of the method of Elson and Morgan and others 
(26, 27,  16)  in which the hydrolysis is carried out in a  5.0  ml volumetric flask. N-Acetyl- 
hexosamine was measured by the procedure of Reissig et aL  (28). Nitrogen was measured by 
a  ninhydrin method described recently (29, 30).  The ethanol concentration in the charcoal 
column fractions was determined by a modification of a procedure employing Anstie's reagent 
(31, 16). The methods used are also given in reference 20. 
Paper Chromatography.--Chromatograms  were run on Whatman No. 1 or Schleicher and 
9 Serum generously supplied  by  Dr.  Scott  Swisher. 
lo Obtained from Mann Research Labs. 
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Schiill No.  589 green label paper,  using a  1-propanol-ethyl acetate-water  (7:1:2)  solvent 
(32),  and developed with alkaline silver nitrate  (33,  34). 
P~SL~TS 
Enzyme  Fractionation.--The  fractionation  of  a  concentrated  Cl.  tertium 
culture supernatant on a DEAE  cellulose  column is illustrated by the chro- 
matogram reproduced in Fig. 1. Under the conditions specified,  beta galacto- 
sidase,  beta  glucosaminidase, and  peptidase  activities  were  retained  on  the 
column, neuraminidase and peptidase activities, and the enzyme which acts 
on blood group A substance appear in the breakthrough volume. The A enzyme 
is retained on the column at NaC1  concentrations below 0.9 per cent; 1 to 5 
per cent of the total activity may be held on the column at 0.9 per cent NaCI. 
The recovery of galactosidase and glucosaminidase activities ranged from 75 
to 100 per cent. 
As seen in Fig. 1, the peak of galactosidase activity is only one tube (20 ml) 
ahead of that for glucosaminidase. This degree of separation could be improved 
somewhat  by  rechromatography  on  DEAE  with  the  collection  of  smaller 
fractions, and by using stepwise elution with closely spaced NaC1 concentra- 
tions.  In  this manner fractions with beta  glactosidase activity with no de- 
tectable beta glucosamlnidase activity were  obtained from the  front of the 
peak, but the beta galactosidase peak always overlapped the glucosaminidase 
region and it was not possible to obtain glucosaminidase without appreciable 
galactosidase activity. It should be noted that the method of assay for galacto- 
sidase is much more sensitive than that for glucosaminldase. 
A  beta  glucosaminidase preparation  with  low beta  galactosidase  activity 
was  obtained  in  the  following manner.  The  fractions  containing  the  peak 
galactosidase and glucosaminidase activities (fractions 89 to 94,  Fig.  1)  were 
pooled and rechromatographed on a  DEAE cellulose  column, using stepwise 
elution with NaC1.  Both the glucosaminidase and galactosidase were eluted 
at 0.30 ~r NaC1  and were separated from the peptidase, which was eluted at 
0.25 ~r NaC1. The glucosamlnidase-containing fractions were pooled, excluding 
the earlier beta galactosidase peak fractions, concentrated by dialysis against 
carbowax 20000 and subjected to electrophoresis on a pevikon block. As seen 
in Fig. 2, the material eluted from segment -}-7 had a  considerably enhanced 
ratio of beta glucosaminidase/beta galactosidase activities. 
Enzymalic  Treatment of Erythrocytes.--The  enzyme activity in  tmconcen- 
trated Cl. tertium culture supematants was too low for use in treatment of red 
cells.  The unfractionated, concentrated supernatant  could be  employed but 
long treatment is required, several hours to overnight, because of the relatively 
low glucosaminidase activity. In addition, as noted previously (14), after treat- 
ment with  the  unfractionated supernatant  the  cells  became  agglutinable in 
autologous serum. In general, the DEAE cellulose  column fractions with peak :~q/~ OG/VOOZg  AJJSN30  3VOIldO 
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beta galactosidase and beta glucosaminidase activities were pooled to provide 
a preparation for treatment of red cells or stroma. These pooled preparations 
contained variable amounts  of peptidase  activity, but  this  did not interfere 
with  the  determination  of  erythrocyte  reactivity  with  anti-I  agglutinln% 
fractions with high peptidase activity but no galactosidase or glucosaminidase 
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FIo. 2. Separation of beta galactosidase and beta glucosamlnldase from CI.  terlium by 
zone electrophoresis  in a pevikon block 7 X  1.2 X 29 cm. Electrophoresis  was carried out 
for 17 hours at 200 v, 16 to 24 ma, in 0.07 ~ phosphate buffer, pH 6.5. The block was cut 
into 1 cm segments. 
activity; e.g., fraction 88, Fig.  1, did not alter the I  activity of red cells,  nor 
did any of the fractions from the earlier part of the chronmtogram. 
The data in Table I illustrate the decrease in reactivity with anti-I of groups 
A1  and  O  erythrocytes treated  with  a  preparation  containing  beta  galacto- 
sidase and beta glucosamln~dase. Two important features of this data should 
be noted: the differences among the three anti-I sera in the extent of decrease 
in titer against treated cells; and the effect of the ABO group of the cells on 
their  susceptibility  to  enzymatic  modification.  Thus,  when  titrated  simul- 
taneously against  A1  cells from a  single  treated sample,  sere Bu.,  Ch.,  and 182  ACTION OF ENZYMES  FRO3~ CLOSTRIDIU3~ TERTIUM 
TABLE  I 
The Effect  of Treatment* with C1. tertium Beta Galactosidase and Beta Glucosaminidase on 
the Agglutinability  of Group A~ and 0  Erythrocytes by Anti-I Cold Agglutinins and 
Type XIV Antipneumococeal  Horse Serum 
Serum Bu.--reeiprocal of dilution 
A~ cells  Untreated 
Enzyme-treated 
0 cells  Untreated 
Enzyme-treated 
2  4  8  16  32  64  128  Saline 
++++~[++++[++++  ++++  +++4.+++  +4-  o 
0  0  0  0  0  0  0  0 
++++  ++++]++++]++++]++++i++++]+++± I  o 
+++4-  +++  ++  o  o  o  o  o 
Serum Ch.--reciprocal of dilution 
AI cells  Untreated 
Enzyme-treated 
0  cells  Untreated 
Enzyme-treated 
4  8  16  32  64  128  2.56  512  1024 2048 4096  lineSa- 
++++  ++++  ++++  ++++  ++++  +++4-]+++4- ++  [+~-[ o  [  o [  o 
++  ++  ++  +4-  +  o  o  o  o  o  o  o 
-F+++  ++++  ++++  ++++  ++++  ++++  +++4- ++  +4-  +  o  o 
++÷+  ++++  ++++  ++++  ++++  ++++  +++  +  o  o  o  o 
Serum N. P.--reciprocal of dilution 
A1cens  Untreated 
Enzyme-treated 
0  cells  Untreated 
Enzyme-treated 
4  8  16  32  64  128  256  512  1024 2048 4096  llneSa" 
++++  ++++  ++++[++++  ++++[++++[++4.  ++4- +4-  4.  0  0 
+++  ++  ++  ++  +4-  +±  +4-  o  o  o  o  o 
++++  ++++  ++++  ++++  ++++  ++++  +++4.]++4.[+±  I 4. I  o  o 
++++  ++++  ++++  ++++  ++++  ++++  ++÷4- ++.4- ++  +  o  o 
Serum Bu.--reclprocal of dilution 
AI cells  Untreated 
Enzyme-treated 
O cells [ Untreated 
Enzyme-treated 
2 
++++ 
o 
++++ 
++ 
++++  ++++  +++±  ++4-  ++ 
0  0  0  0  0 
++++  ++++]+++ +  ++++  ++4-  o+~-  ++  4-  0  0  0 
512  Saline 
o 
o 
o 
Horse 615 Type XIV antipneumococcal specific polysaccharidc (SXXV)--reciprocal  of dilution 
As cells  Untreated 
Enzyme-treated 
O cells  Untreated 
Enzyme-treated 
2  4  8  16  32  i  64  i saline 
~ +++  +++±++  +  0  0 
0  0  0  0 
++++  ++++++++++++[++± 
++  ++±  +~  ~  0 
* A 4  per  cent  suspension of  the  erythrocytes was incubated  in  the  enzyme preparation  for 
2 hours at 37°C. 
:~ Agglutination is graded from 0  to ++++;  +  to ++  represent agglutination, as read with 
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N.  P.  showed a  decrease in titer of 7,  4,  and 2 tubes,  respectively; with O 
cells  the decreases were only 4,  2, and 0  tubes, respectively. The decrease in 
reactivity of A1 cells with sera Ch. and N. P. was also manifested by the weak- 
ened agglutination produced by the lower serum dilutions. AI cells were found 
to be most susceptible to enzymatic attack and O cells least susceptible; A2, B, 
and A1B  ceils were intermediate in susceptibility to alteration. Treatment of 
O erythrocytes for periods up to 18 hours at 37°C produced a progressive loss 
in agglutinability, but prolonged incubation at this temperature was limited 
by increasing red cell fragility. 
The cross-reaction of Type XIV antipneumococcal horse serum with human 
blood group substances is known to involve non-reducing beta galactosyl end 
groups (35, 36).  It has also been demonstrated that treatment of human and 
hog blood group substances with a  crude unfractionated enzyme preparation 
from Cl. tertium  virtually abolished this cross-reaction (15).  As seen in Table 
I, treatment of human erythrocytes with partially purified beta galactosidase 
and  beta  glucosaminidase reduces  their  agglutinability by Type XIV  anti- 
pneumococcal horse serum. A1 ceils were more susceptible to the enzyme than 
were O cells. 
Specif~ity  of the Erythrocyte  Alteration.--Enzyme-treated  .%1  erythrocytes, 
which were not agglutinated by a  1:2 dilution of serum Bu. at 20°C, displayed 
no detectable alteration in their reactivity with the following reagents: anti-A1 
(Dolichos  biflorus  extract),  anti-B,  anti-H  (Ulex  europeus  extract),  anti-P 
(anti-Tj  a) and anti-P1, anti-Rh (1, 2, 5, and 7 [D,  C, e, Ce]),  anti-M (rabbit), 
anti-N  (Vicia  graminea  extract),  anti-S,  anti-s,  anti-Le%  anti-Le  b,  anti-K2 
(Cellano),  anti-Jk%  anfi-Fy  a,  and  anti-Ge.  A  sample  of  anti-i  12  revealed  a 
slight reduction in reactivity:adnlt cells  scored 9 ,ersus 21  for the untreated 
control, and cord blood scored 53 versus 60 for the untreated control. 
Requirement for Both Beta Galactosidase and Beta Glucosaminidase Activities.- 
Preparations  which  contained beta galactosidase with little or no beta glu- 
cosaminidase were much less effective in decreasing the I  activity of red ceils 
than were  those containing both  enzymes. Table  II presents  the  results  of 
treatment  of  erythrocytes with  DEAE  cellulose  column  fractions  of  a  Cl. 
tertium cnlture which had been grown on a medium containing lactose but no 
glucosamine. Fractions 102  and 104, which were low in beta glucosaminidase 
activity, were unable to make the cells  inagglutinable by a  1:16  dilution of 
serum Bu., despite their high beta galactosidase activity relative to fraction 
114. 
The  effect of glucosaminidase alone  could not be  tested,  inasmuch as  no 
preparation without beta galactosidase activity was obtained. A glucosamini- 
dase preparation with low galactosidase activity, eluted from pevikon segment 
n Kindly supplied by Dr. W. J. Jenkins, Northeast Metropolitan Regional Blood Trans- 
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+7,  Fig.  2,  produced a  slight  decrease in  the  agglutinability of A1  cells by 
sera Bu. and Ch. A bacterial beta glucosaminidase which acts on the strepto- 
coccal  Group  A  carbohydrate  13  (37)  was  without  effect  on  erythrocyte I 
activity. 
It is difficult to provide an exact estimate of the amount of enzyme activity 
required  to  alter  the  erythrocyte I  determinant  because  of several  factors: 
differences in susceptibility to enzymatic modification among cells of different 
ABO groups; differences among anti-I sera; and  the limited precision of the 
conventional hemagglutination system employing serial twofold  dilutions. As 
an approximation, A1 cells  became completely inagglutinable by a  1:16 dilu- 
TABLE  II 
The Effect of Trealment*  wltk Enzyme-Containing  Fractions from a DEAE 
Cdlulose  Column on the A gglutinability  of A z Erythrocytes  by Anti-! 
Fraction No. 
No treatment 
90 
100 
102 
104 
108 
111 
114 
Beta galactosldase 
activity OD 4050 
A/0.1 ml/30 rain. 
o 
3.7 
23 .o 
28.0 
11.5 
6.8 
4.5 
Beta glucosamini- 
dase activity OD 
5440 A/0.1 ml/14 
hrs. 
o 
0.024 
0.025 
0.049 
0.111 
0.254 
0.204 
Serum Bu. 1:16 
++++ 
++++ 
+++ 
+± 
o 
0 
0 
Saline 
* A  4  per cent suspension of erythrocytes was suspended in the enzyme preparation for 
30 minutes at 36°C. 
tion of serum Bu. after incubation of cells at a  concentration of 4 per cent at 
37°C for 30 minutes in an enzyme preparation with beta galactosidase activity 
of 3.000 optical density units at 4050 A/0.1 ml/30 minutes and beta glucosa- 
minidase activity of 0.075 to 0.100 optical density units at 5440 A/0.1 ml/hour. 
Treatment of Erythrocyte Stroma.--Since  intact red cells could be incubated 
at 37°C for only limited periods of time, stromata were employed as substrate, 
and  the  ability  of  enzyme-treated and  untreated  stroma  to  absorb  anti-I 
agglutinins was determined. As can be seen in Table HI, stroma derived from 
A1 cells lost all ability to absorb anti-I agglutinins after overnight incubation 
with an enzyme preparation containing beta galactosidase and beta glucosa- 
minidase.  Treatment of equivalent  amounts  of B  and  O  stromata  with  the 
same enzyme preparation resulted in only limited loss of absorptive capacity 
for anti-I. Retreatment of a  stroma aliquot for 72 hours at twice the original 
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enzyme: stroma ratio reduced, but did not eliminate,  the reactivity of B  and 
O stromata with anti-I. 
Data on the composition of the supernatant fluids from the original over- 
night treatment of the stroma are given in Table IV. The low nitrogen value 
for the O stroma supernatant resulted from the passage of this material through 
a  charcoal column in 20 per cent ethanol, a step omitted in the vcorkup of the 
TABLE HI 
Absorption of Anti-I Cold Agglutinin (CIr. Serum) by Control and Enzyme-Trea~ed Stromata 
Reciprocal of serum dilution* 
5  10  20  40  80  160  320  640  1280  2560  5120  Saline 
Unabsorbed 
Absorbed with 
Untreated Ax 
stroum 
Enzyme-treated 
At  stroum  17 
hrs. 
Absorbed with 
Untreated B 
stroma 
Enzyme  treated  B 
stroum  19  -t-  72 
hrs. 
Absorbed with 
Untreated O 
stroma 
Enzyme-treated  O 
stroma 18 -}- 72 
hrs. 
++÷÷  ++-t-+ +++÷  ÷+++  +-t-+-I- ÷÷++  +++-~-  +++  +±  +  o  o 
20  40  80  150  320  640  1280  2560  5120  Saline 
0  0  0  0  0  0  0  0  0  0 
+++÷  ÷+++  +++-{- ÷+++  ++++  +++  +4-i  +  0  o 
18  36  72  144  288  576  1152  2304  Saline 
0  0  0  0  0  0  0  0  0 
+-I-H-' ÷÷÷-I- +÷÷÷  ÷-t--I-  +-t-  -~-÷  -t-  o  o 
15  30  60  120  240  480  960  1920  Saline 
0  0  0  0  0  0  0  0  0 
++÷-t- +++÷ ++-t-+ ÷+-t-+  ++÷  ++4-  o  o  o 
"When the serum was absorbed with an equal volume of packed stroms it was assumed  to have undergone a  1:2 
dilution.  All titrstions  were performed with group O  cells. 
A  and  B  stromata.  Paper  chromatography of these  solutions  demonstrated 
that they were extremely complex in composition, and in view of the relative 
non-specificity of the colorimetric analytical methods employed, the solutions 
were chromatographed on charcoal-celite columns. 
As seen in Fig. 3, two peaks appeared in the chromatograms of the super- 
natants from the enzyme-treated stroma, the first was eluted with water, and 
the second was eluted with 2 to 5 per cent ethanol. The fractions in the peak 
areas were pooled and concentrated, and the analytical data on these solutions 
are presented in Table V.  With  all three stroma samples,  paper chromatog- 186  ACTION O]~ ENZYMES ]~ROM CLOSTRIDIUM TERTIU~ 
raphy showed a  single major component with the mobility of galactose in the 
peak eluted with water. Traces of two more slowly moving compounds were 
seen in the B  stroma supernatant.  Galactose has a  reducing sugar equivalent 
as glucose of 79 per cent, and comparison of columns 3 and 4 in Table V shows 
good  agreement  between  galactose  determined  directly and  the  value  cal- 
culated from the  reducing sugar except for the B  stroma supernatant which 
contained very small amounts of sugar. 
The N-acetylhexosamine was tentatively identified  as N-acetylglucosamine 
by  differential  colorimetric  analysis  (38),  since  N-acetylgalactosamine  and 
N-acetylmannosamine yield 31 per cent (38,  16)  and 55 per cent (39)  respec- 
tively of the color value of N-acetylglucosamine. The agreement between N- 
acetylhexosamine values  obtained  by multiplying  the  hexosamine  value  by 
TABLE IV 
Composition of the Supernatant Fluid  from the Untreated and Enzyme-Treated 
Stromata 
A untreated 
A enzyme-treated 
B untreated 
B enzyme-treated 
O untreated 
O enzyme-treated 
Reducing  sugar 
(glucose 
equlvalents) 
78 
285 
10 
54 
127 
263 
C~lactose 
t~dna 
5 
124 
15 
55 
10 
92 
N-Acetylhexos- 
amine 
5 
131 
0 
14 
5 
57 
Nitrogen 
549 
643 
32 
33 
34 
27 
1.23,  and  the  direct  N-acetylhexosamine determination  using  an  N-acetyl- 
glucosamine standard  (Table V,  columns  6  and  7),  indicates  absence of ap- 
preciable amounts  of N-acetylgalactosamine or N-acetylmannosamine. 
Hemagglutination  Inhibition with Anti-I Sera.--Hemagglutination  inhibition 
tests were performed by adding one drop of inhibitor to a drop of diluted serum, 
incubating the mixture at 20°C  or 4°C for 30 minutes,  and then adding  one 
drop of 2 per cent group O cells.  No inhibition of the three anfi-I sera tested 
was found with any of the following compounds: galactose, glucose, mannose, 
N-acetylglucosamlne, lactose, melibiose, or maltose,  all  at  an  initial  concen- 
tration of 50.0 mg/ml;  galactinol 9.4 mg/ml;  alpha methyl-N-acetylglucosa- 
minide  38  mg/ml;  beta  methyl-N-acetylglucosaminide 40  mg/ml;  and  the 
following polysaccharides  at  initial  concentrations  of  approximately  1  to  4 
mg/ml,--Type  XIV  pneumococcal  polysaccharide,  Group  A  streptococcal 
polysaccharide,  13  type  A  Cryptococcus  neoformans  capsular  polysaccharide,  u 
14 Generously  provided by Dr. Irving Abrahams. 9.0 
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FIG.  3.  Chromatography on charcoal-celite columns of sugars released from group A, B, 
and O  erythrocyte stromata by the action of CL lerEum  enzymes. The sugars were applied 
to the column in water; at the first arrow an ethanol gradient was imposed with 25 per cent 
ethanol, and at the second arrow 50 per cent ethanol was used for the gradient. The super- 
natants from the A  and  O  stromata were fractionated  on 8  gm columns at  a  flow rate  of 
40 ml/hour; 3  ml fractions were  collected.  The B  stroma supernatant was fractionated  on 
a  3  gm column at a  flow rate of 20 ml/hour; 3  ml/fractions were collected. 
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and human and hog blood group substances  and their P1  fractions  (40).  In 
addition,  serum Bu.  was  not  inhibited by any of the  following compounds: 
¢z-galactosyl-1  --~  3-galactose  23.7  mg/ml;  ~-galactosyl-1  -~  6-N-acetylglu- 
cosamine  9.2  mg/ml;  /3-galactosyl-1 --~  3-N-acetylglucosamine  18.2  mg/ml; 
/3-galactosyl-1 --~  4-N-acetylglucosamine 23.5  mg/ml;  /~-galactosyl-1  --*  6-N- 
acetylglucosamine 26.3 mg/ml; and lacto-N-tetraose 8.7 mg/ml.  5 
The enzymatic alteration of erythrocytes could be inhibited partially  with 
lactose, and to a  lesser extent with galactose, melibiose, and N-acetylglucosa- 
mine in concentrations of about 12 mg/ml. At this concentration only minimal 
inhibition was produced by glucose, mannose, and maltose. 
TABLE  V 
Analytical Data on Components Obtained by Charcoal Column Chromatography 
of Supernatants From Enzyme-Treated Stroma 
A stroma 
B stroma 
O stroma 
Reducing 
sugar 
(glucose 
equivalents) 
I~g/ml 
125 
48 
95 
Peak I  Peak H 
Reducing 
sugar X 1.25 
156 
60 
119 
C-alactose 
~g/ml 
150 
44 
106 
Hexosamine 
g.g/r,g 
100 
25 
32 
Hexosamlne 
X 1.23 
Izg/ml 
123 
31 
39 
N-scetyl- 
hexosamine 
~g]ml 
125 
33 
37 
DISCUSSION 
The ability of Cl. tertium  enzymes to decrease the reactivity of anti-I sera 
with erythrocytes and stroma is dearly demonstrated by the data in Tables 
I  and 111. However, interpretation of the data is limited by the semiquantita- 
tive nature of the assay system, and the apparently heterogeneous nature of 
both the I  antigen and anti-I. 
Since one cannot at present determine directly the number of active I  sites 
on the  erythrocyte surface, it  is  necessary to measure  the  effect of enzyme 
treatment  by assaying  erythrocyte agglutinability,  or the  ability of cells or 
stromata to absorb antibody. Moreover, the fraction of the original I  receptors 
which must be altered to produce a decrease in agglutinability is  not known, 
so that this type of assay serves as a  very crude estimate of the number of 
sites affected. The weak reaction of treated A1 cells with a wide range of dilu- 
tions of serum N.  P.  (Table I) illustrates the difficulty of attempting to cor- 
relate the extent of enzyme action with change in titer. The use of stroma as 
a  substrate allows a  more protracted period of enzymatic treatment, and the 
ability of stroma to absorb anti-I provides a more direct estimate of the num- 
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The heterogeneous nature of the I antigen was noted by Wiener (10), who classified 
I cells into subgroups I1, I2, etc., based on their reactivity with anti-I at room tempera- 
ture. This notation has not been generally accepted since cells from random donors 
appear  to fall  on a  continuous normal  distribution  curve with  respect  to antigen 
strength (5,  11). The use of the designation "i" for all cells which react weakly with 
high titer antisera is now felt to be inadequate,  and a  classification into  subgroups 
il, i2, and i(oo,  d  ) is used (42,  12; 8, p. 328), in which the cells are listed in order of in- 
creasing  I  strength. 
The difference  between group AI and O erythrocytes in susceptibility to enzymatic 
action on the I receptor(s) is another manifestation of the heterogeneous nature of this 
blood group system. Factors which conceivably could be involved in this differential 
susceptibility include: differences  in the total number of receptor sites present on cells 
of the various ABO phenotypes; heterogeneity in structure of the I determinants and 
differences  in the accessibility of the I receptors to the enzymes. A large difference in 
the number of I receptors on A1 and O cells seems unlikely in view of the grossly similar 
titers obtained with the I  antisera employed. With regard to heterogeneity of I  de- 
terminants, the ability of stroma of any ABO group to absorb anti-I completely makes 
it unlikely that a fraction of the I antibodies reacts exclusively with O cells. However, 
it is possible that determinant  groups of similar,  but not identical,  structure could 
cross-react extensively, but differ appreciably in their susceptibility to enzymatic hy- 
drolysis. The last possibility, as well as differences in the accessibility to enzyme action 
of the I  determinants  on erythrocytes of different blood groups, provide the most 
likely explanation on the basis of the existing data. 
A number of observations have led to the consideration of an "association" between 
the I and ABO systems (9; 8, p. 334). These include the preferential reactivity of some 
auti-I sera with specific ABO phenotypes (11, 9); the weak reaction of cells from one 
il and one i~ individual with anti-H and anti-"O" reagents (11, 9); and the presence of 
"naturally occurring" anti-I in most of the i individuals reported (11, 9, 12). Wiener 
(43) has suggested that cold auto-antibodies might be directed at the "nucleus" of the 
ABO complex. At present, there is no evidence of genetic linkage between the genes 
of the ABO and I loci (8). The occurrence of the erythrocyte I determinants as discrete 
structures apart from the ABO determinants is suggested by the absence of abnormali- 
ties in the ABO phenotype of most i cells, and the normal I  strength of "Bombay" 
cells (11, 9, 21), a rare type of erythrocyte which is not agglutinated by anti-A, anti-B, 
or anti-H (44). It is possible that the "association" of the ABO and I groups is spatial 
in nature, rather than genetic, and that the influence of ABO phenotype on agglutin- 
ability by anti-I, or susceptibility  of the I  determinant  to enzymatic attack,  is  a 
manifestation of steric interaction of adjacent I  and ABO structures on the erythro- 
cyte membrane. 
There  is  a  gross parallelism  in the behavior of enzymatically-treated A1 and  O 
erythrocytes with anti-I and Type XIV antipneumococcal horse sera (Table I). In 
addition, Levine et at. noted that horse Type XIV antipneumococcal sera agglutinated 
O and A~ cells more strongly than A1 cells, and that these sera could be partially ab- 
sorbed with A~ cells in such a manner that they agglutinated O and A2 cells but not 
A1  cells  (45).  These  observations  raise  the  question  of  whether  these  anti-I 
and anti-XIV sera are reacting in part with the same determinants. The Type XIV 190  ACTION OF ENZYMES FRO3~ CLOSTRIDI~  TERTIU~I 
antipneumococcal horse serum used in this study agglutinated il ceils, 15 indicating that 
the two types of antisera are not reacting extensively with the same determinants. 
Even if the I  determinant  should also prove to have a  terminal beta galactosyl 
residue, it has already been demonstrated that two antigenic determinants may have 
the same terminal non-reducing sugar, in the same anomeric form, and show little or 
no cross-reactivity (40, 41, 46). 
Anti-I sera also appear  to differ  in specificity.  A  division of these sera into sub- 
groups anti-I  ~ and anti-I  b has been proposed (47), based on their differential reactivity 
with  umbilical cord cells.  Anti-I sera also vary widely in the extent to which they 
are inhibited by sheep liver hydatid cyst fluid (9, 12). The differences among the anti-I 
sera used in this study in the extent to which they reveal a  decrease in titer with a 
single  sample  of enzyme-treated cells,  may reflect  differences  in  specificity and/or 
heterogeneity  in  size  of  combining  sites  (cf.  20,  p.  342,  for  general  discussion 
of heterogeneity of antibodies). 
The data in this report do not establish a causal relationship between the release of 
galactose and N-acetylglucosamine from the erythrocyte membrane and the decrease 
in I  antigen  activity.  The  beta galactosidase and  beta  glucosaminidase were  only 
partially purified,  and  the possibility exists  that unknown contaminating enzymes 
are responsible for, or participate in,  the alteration of the I  determinant. 
Assuming, for the sake of discussion,  a causal relationship  between the release of 
both galactose and N-acetylglucosamine and the loss of I activity, the role of these two 
sugars in the I  determinant should be considered. The partial loss of I  activity pro- 
duced by treatment  with  beta galactosidase preparations without appreciable  beta 
glucosaminidase activity indicates  a  terminal,  non-reducing location for at  least  a 
portion of the galactose residues.  No inferences can be drawn from the available in- 
formation as  to whether N-acetylglucosamine occurs in  a  subterminal  position,  in 
glycosidic linkage with  galactose,  or in a  terminal position, presenting  a  branched 
determinant,  analogous to that postulated by Watkins and Morgan for the Le  ~ de- 
terminant  (48). 
The significance of the differences in the amounts of galactose and N-acetyl- 
glucosamine liberated  from the  A,  B,  and O  stromata  (Table  IV)  is  also not 
clear, since a  very limited  number of stroma preparations  were used,  and the 
fraction  of  the  released  sugar  actually  related  to  the  I  determinant  is  un- 
known. 
A  variety  of  low  molecular  weight  compounds  containing  galactose  and 
N-acetylglucosamine failed to inhibit hemagglutination by the three I  antisera 
examined.  Although  these  data  provide  no  support  for the  suggested  occur- 
rence  of these  sugars  in  the  I  determinant,  they do not militate  against  this 
possibility.  It is extremely difficult to inhibit with oligosaccharides the hemag- 
glutinating  activity  of many  sera.  For  example,  0.17  to  0.34  mg  of lactose 
produced 50 per cent inhibition of the precipitation of a variety of blood group 
substances  by 0.5  ml  of the  Type XIV horse  antipneumococcal  serum  used 
15 Generously provided by Dr. R. R. Race. D.  M.  MARCUS,  E.  A.  KABAT,  AND R.  E.  ROSEN'FIELD  191 
in this study (36). Agglutination d  O erythrocytes by 0.1 ml of a 1:20 dilution 
of the same antiserum could not be inhibited by 3 mg of lactose. The failure 
of  polysaccharides  with  non-reducing  beta  galactosyl  and  beta-N-acetyl- 
glucosaminoyl groups  to  cross-react  with  the  anti-I  sera  is  similarly unin- 
formative. As noted above, two antigenic determinants with the same terminal 
sugar residue may show no appreciable cross-reactivity. 
A more direct approach to the elucidation of the structure of the I  deter- 
minant would be  to extract and characterize material from the erythrocyte 
cell  membrane,  and  work  along  these  lines  is  planned.  Delineation  of  the 
structure of the I  and i determinants would be of interest in several respects: 
it would add to our knowledge of the relationship between chemical structure 
and  antigenic specificity (49),  investigation of the biochemical lesion which 
leads to the adult i phenotype would be facilitated; and a  knowledge of the 
specificity of  this  autoantibody would  aid  in  studying the  pathogenesis  of 
hemolytic anemia associated with cold agglutinins. 
S~MM.ARY 
A  method was described for the partial purification of beta galactosidase 
and  beta  ghicosamlnidase  from  Clostr~tium  tertium  culture  supernatants. 
Treatment  of  erythrocytes with  preparations  containing both  enzymes de- 
creases their ability to react with anti-I cold agglutinins, and with Type XIV 
antipneumococcal horse  serum.  Erythrocytes of blood  group  At are  altered 
more rapidly and extensively than are group O cells. The enzymatic treatment 
of stroma results in a  decrease in ability to absorb anti-I agglutinins and the 
release  of galactose and N-acetylglucosamine as monosaccharides. The data 
suggest that  these two sugars may be  structural units of the  erythrocyte I 
determinant, but no direct evidence is available. 
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